CA3242451A1 - An injectable pharmaceutical composition for the treatment of respiratory diseases in animals - Google Patents

An injectable pharmaceutical composition for the treatment of respiratory diseases in animals

Info

Publication number
CA3242451A1
CA3242451A1 CA3242451A CA3242451A CA3242451A1 CA 3242451 A1 CA3242451 A1 CA 3242451A1 CA 3242451 A CA3242451 A CA 3242451A CA 3242451 A CA3242451 A CA 3242451A CA 3242451 A1 CA3242451 A1 CA 3242451A1
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
injectable pharmaceutical
animals
treatment
respiratory diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3242451A
Other languages
English (en)
French (fr)
Inventor
Chen-Chao Wang
Thorsten Meyer
Ralf Warrass
Joachim Ullrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of CA3242451A1 publication Critical patent/CA3242451A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CA3242451A 2021-12-24 2022-12-23 An injectable pharmaceutical composition for the treatment of respiratory diseases in animals Pending CA3242451A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21217704 2021-12-24
EP21217704.2 2021-12-24
PCT/EP2022/087700 WO2023118557A1 (en) 2021-12-24 2022-12-23 An injectable pharmaceutical composition for the treatment of respiratory diseases in animals

Publications (1)

Publication Number Publication Date
CA3242451A1 true CA3242451A1 (en) 2023-06-29

Family

ID=79601675

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3242451A Pending CA3242451A1 (en) 2021-12-24 2022-12-23 An injectable pharmaceutical composition for the treatment of respiratory diseases in animals

Country Status (9)

Country Link
US (1) US20250057790A1 (cg-RX-API-DMAC7.html)
EP (1) EP4452226A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024544415A (cg-RX-API-DMAC7.html)
CN (1) CN118632684A (cg-RX-API-DMAC7.html)
AR (1) AR128074A1 (cg-RX-API-DMAC7.html)
AU (1) AU2022420882A1 (cg-RX-API-DMAC7.html)
CA (1) CA3242451A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024007862A (cg-RX-API-DMAC7.html)
WO (1) WO2023118557A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021335500A1 (en) 2020-09-04 2023-05-04 Elanco Us Inc. Palatable formulations
AR134777A1 (es) 2023-12-21 2026-04-01 Intervet Int Bv Formas cristalinas de sales de (s)-n-(3-amino-1-(hidroxiamino)-3-metil-1-oxobutan-2-il)-4-((4-(((2-metoxietil)amino)metil)fenil)etinil)benzamida
CN122422289A (zh) 2023-12-21 2026-07-17 英特维特国际股份有限公司 (s)-n-(3-氨基-1-(羟基氨基)-3-甲基-1-氧代丁-2-基)-4-((4-(((2-甲氧基乙基)氨基)甲基)苯基)乙炔基)苯甲酰胺盐的结晶形式的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3740421A (en) 1966-09-19 1973-06-19 Basf Wyandotte Corp Polyoxyethylene-polyoxypropylene aqueous gels
JP7082445B2 (ja) 2016-12-23 2022-06-08 インターベット インターナショナル ベー. フェー. ウシ又はブタの呼吸器疾患を治療するための化合物

Also Published As

Publication number Publication date
WO2023118557A1 (en) 2023-06-29
US20250057790A1 (en) 2025-02-20
AU2022420882A1 (en) 2024-06-20
MX2024007862A (es) 2024-07-09
JP2024544415A (ja) 2024-11-29
EP4452226A1 (en) 2024-10-30
AR128074A1 (es) 2024-03-20
CN118632684A (zh) 2024-09-10

Similar Documents

Publication Publication Date Title
MX2024007862A (es) Una composicion farmaceutica inyectable para el tratamiento de enfermedades respiratorias en animales.
GEP20002298B (en) Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
JP2007500697A5 (cg-RX-API-DMAC7.html)
BRPI0618374A2 (pt) uso de um composto ou um derivado do mesmo farmaceuticamente aceitável, métodos para matar microorganismos clinicamente latentes em um mamìfero, para tratar ou prevenir uma infecção microbiana em um mamìfero, para esterilizar um objeto, para preservar um material inorgánico ou orgánico, para tratar uma doença, para reduzir a dose de agente antimicrobiano convencional requerida para tratar uma infecção microbiana e para tratar uma doença de protozoário em um mamìfero, produto combinado, formulação, uso de um produto combinado, composto, e, processo para a preparação do mesmo
EP0820281B1 (en) A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses
RU2414902C1 (ru) Бактерицидная композиция для профилактики и лечения инфекционных заболеваний копыт у животных
SE9901573D0 (sv) New compounds
RU94008616A (ru) 2-тиозамещенные карбапенемы, промежуточные соединения для получения, способы получения, фармацевтическая композиция, способ лечения бактериальных инфекций
Adegbeye et al. Potential of silver nanoparticles for veterinary applications in livestock performance and health
RU2107502C1 (ru) Ветеринарный препарат, обладающий широким спектром действия, - йод однохлористый
JP2013539466A5 (cg-RX-API-DMAC7.html)
CA2386685A1 (en) Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
CN114712355B (zh) Rhps4在制备抑制金黄色葡萄球菌和铜绿假单胞菌药物中的应用
AU5643299A (en) Humic acid and its use in the treatment of various conditions
EP2250887B1 (en) Use of non-antibacterial tetracycline analog CMT-1002 and formulations thereof for the treatment of bacterial exotoxins
KR100227125B1 (ko) 미포자충감염을치료하기위한벤즈이미다졸구충제의용도
RU2203035C1 (ru) Фармацевтическая композиция с дезинфицирующими, спороцидными и ранозаживляющими свойствами
EP0992241A4 (en) MEDICAL COMPOSITIONS AGAINST HELICOBACTER PYLORI
AU4519189A (en) Medicaments for the treatment of toxoplasmosis
RU2083207C1 (ru) Способ лечения экспериментального сапа у золотистых хомячков
HUT62474A (en) Process for producing veterinary composition with antiparasitic effect
RU2005140156A (ru) Применение аивлозина для лечения болезней, вызванных brachyspira pilosicoli или ornithobacterium rhinotracheale
PT1059845E (pt) Composicao fungicida compreendendo uma benzoilfenilureia
RU1818095C (ru) Препарат дл профилактики и лечени бронхопневмании сельскохоз йственных животных
JP2002284604A (ja) 抗菌防黴助剤